Claney L. Pereira - Concepedia

Author

Claney L. Pereira

Max Planck Institute of Colloids and Interfaces ORCID

Also Known As

C L Pereira, C. L. Pereira, Claney L Pereira, Claney L. Pereira, Claney Lebev Pereira, Claney Pereira, Claney L. Pereira, Claney Lebev Pereira, Pereira, C.

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Max Planck Institute of Colloids and Interfaces Freie Universität Berlin Charité - Universitätsmedizin Berlin Max Planck Society Emory University

About

Claney L. Pereira is an author at Max Planck Institute of Colloids and Interfaces specializing in medicine, microbiology, and glycobiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	14	908
2	Biochemistry	6	6	316
3	Engineering	5	5	228
4	Natural Sciences	5	5	236
5	Health Sciences	2	2	280

Claney L. Pereira

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Methicillin-resistant Staphylococcus aureus alters cell wall glycosylation to evade immunity David Gerlach, Yinglan Guo, Cristina De Castro, Nature Antimicrobial SusceptibilityHealth SciencesGlycosylationGlycobiologyMicrobiology	2018	195
Microbe-focused glycan array screening platform Andreas Geissner, Anika Reinhardt, Christoph Rademacher, Proceedings of the National Academy of Sciences Bioorganic ChemistryGlycan Binding ProteinsGlycobiologyMolecular BiologyPolysaccharide	2019	91
A Semi‐Synthetic Glycoconjugate Vaccine Candidate for Carbapenem‐Resistant <i>Klebsiella pneumoniae</i> Peter H. Seeberger, Claney L. Pereira, Naeem Khan, Angewandte Chemie International Edition VaccinationSemi-synthetic GlycoconjugateVaccine DevelopmentHealth SciencesHospital-acquired Infections	2017	85
A semisynthetic <i>Streptococcus pneumoniae</i> serotype 8 glycoconjugate vaccine Benjamin Schumann, Heung Sik Hahm, Sharavathi G. Parameswarappa, Science Translational Medicine	2017	83
Total Synthesis of a Densely Functionalized <i>Plesiomonas shigelloides</i> Serotype 51 Aminoglycoside Trisaccharide Antigen Chunjun Qin, Benjamin Schumann, Xiaopeng Zou, Journal of the American Chemical Society Bioorganic ChemistryEngineeringMicrobial PathogensGlycobiologyPolysaccharide	2018	80
Synthesis, Liposomal Formulation, and Immunological Evaluation of a Minimalistic Carbohydrate-α-GalCer Vaccine Candidate Felix Broecker, Sebastian Götze, Jonathan Hudon, Journal of Medicinal Chemistry Conventional Glycoconjugate VaccineEngineeringGlycobiologyImmunologyImmunodominance	2018	63
Improving vaccines against <i>Streptococcus pneumoniae</i> using synthetic glycans Paulina Kapłonek, Naeem Khan, Katrin Reppe, Proceedings of the National Academy of Sciences	2018	61
A <i>Streptococcus pneumoniae</i> Type 2 Oligosaccharide Glycoconjugate Elicits Opsonic Antibodies and Is Protective in an Animal Model of Invasive Pneumococcal Disease Madhu Emmadi, Naeem Khan, Lennart Lykke, Journal of the American Chemical Society Microbial PathogensImmunologyInvasive Pneumococcal DiseasesIs ProtectiveImmunotherapy	2017	60
A Semi-synthetic Oligosaccharide Conjugate Vaccine Candidate Confers Protection against Streptococcus pneumoniae Serotype 3 Infection Sharavathi G. Parameswarappa, Katrin Reppe, Andreas Geissner, Cell chemical biology VaccinationVaccine DevelopmentImmunologySerotype 3Microbiology	2016	57
Semisynthetic glycoconjugate vaccine candidate against <i>Streptococcus pneumoniae</i> serotype 5 Marilda P. Lisboa, Naeem Khan, Christopher E. Martin, Proceedings of the National Academy of Sciences	2017	52

Page 1